Chlamydia conjunctivitis: Difference between revisions
| (One intermediate revision by one other user not shown) | |||
| Line 33: | Line 33: | ||
==Evaluation== | ==Evaluation== | ||
===Workup=== | |||
===Diagnosis=== | |||
==Management== | ==Management== | ||
===Adult=== | ===Adult=== | ||
*Systemic antibiotics | *Systemic antibiotics | ||
*[[Azithromycin]] 1g PO x1 | *[[Azithromycin]] 1g PO x1 or doxycycline 100 mg BID for 7 days | ||
*Topical antibiotics | *Topical antibiotics | ||
**Topical [[erythromycin]] ointment BID-TID x2-3 weeks | **Topical [[erythromycin]] ointment BID-TID x2-3 weeks | ||
Latest revision as of 19:54, 6 July 2022
Background
- Caused by Chlamydia
Types
- Trachoma
- Serotypes A through C
- Chronic keratoconjunctivitis
- Most common form of preventable blindness in the world
- Inclusion conjunctivitis
- Serotypes D through K
- Common, primarily sexually transmitted disease
- Affects both newborns and adults
Clinical Features
Newborns
- Tearing
- Conjunctival inflammation
- Eyelid swelling
- Moderate discharge
- Starting 5-12 days after birth
Adults
- Infection can be subacute or chronic
- Most common in young, sexually active persons aged 18 to 30 years
- Unilateral or bilateral redness
- Foreign body sensation
- Mucopurulent discharge
- Pre-auricular adenopathy
Differential Diagnosis
Conjunctivitis Types
Evaluation
Workup
Diagnosis
Management
Adult
- Systemic antibiotics
- Azithromycin 1g PO x1 or doxycycline 100 mg BID for 7 days
- Topical antibiotics
- Topical erythromycin ointment BID-TID x2-3 weeks
- Consider ceftriaxone for empiric gonorrhea coverage
Neonatal
Inclusion conjunctivitis
- Systemic antibiotics
- Erythromycin elixir 50mg/kg/d divided QID
- Topical antibiotics
- Erythromycin ointment QID
- Consultation with ophthalmology
- Special cultures may be required
Disposition
- Discharge with ophtho follow-up.